Tearsheet

Sabra Health Care REIT (SBRA)


Market Price (12/22/2025): $18.78 | Market Cap: $4.5 Bil
Sector: Real Estate | Industry: Health Care REITs

Sabra Health Care REIT (SBRA)


Market Price (12/22/2025): $18.78
Market Cap: $4.5 Bil
Sector: Real Estate
Industry: Health Care REITs

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 10%, Dividend Yield is 6.4%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 6.1%, FCF Yield is 7.6%
Trading close to highs
Dist 52W High is -4.2%, Dist 3Y High is -4.2%
Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 54%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 46%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 46%
  Key risks
SBRA key risks include [1] significant tenant concentration, Show more.
2 Low stock price volatility
Vol 12M is 23%
  
3 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease. Themes include Geriatric Care.
  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 10%, Dividend Yield is 6.4%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 6.1%, FCF Yield is 7.6%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 46%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 46%
2 Low stock price volatility
Vol 12M is 23%
3 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease. Themes include Geriatric Care.
4 Trading close to highs
Dist 52W High is -4.2%, Dist 3Y High is -4.2%
5 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 54%
6 Key risks
SBRA key risks include [1] significant tenant concentration, Show more.

Valuation, Metrics & Events

SBRA Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

Here are five key points explaining the -0.6% stock movement for Sabra Health Care REIT (SBRA) from August 31, 2025, to December 22, 2025:

**1. Q3 2025 Revenue Miss:** Sabra Health Care REIT reported its third-quarter 2025 revenue of $190.04 million, which fell below analysts' consensus estimate of $193.44 million. This revenue miss, despite a beat on earnings per share, likely contributed to a slight negative market reaction.

**2. Share Dilution from Equity Offerings:** During the third quarter of 2025, Sabra issued 9.6 million shares from outstanding forward sale agreements, generating $165.0 million in net proceeds. Additionally, on August 5, 2025, the company established a new $750 million At-The-Market (ATM) program, allowing for the sale of up to 3.2 million shares. These equity issuances could have raised concerns about share dilution, placing mild downward pressure on the stock.

**3. Mixed Analyst Ratings and Price Target Adjustments:** Investor sentiment was potentially tempered by a mixed bag of analyst ratings during the period. While some analysts maintained "Buy" or "Overweight" ratings, UBS initiated coverage with a "Hold" rating on November 18, 2025, and Wall Street Zen reportedly lowered shares to a "Sell" rating on November 8, 2025. This divergence in analyst opinions could have contributed to a more cautious outlook for the stock.

**4. Updated 2025 Guidance:** On November 5, 2025, Sabra updated its 2025 earnings guidance. While the full implications of this update are not detailed as overtly negative, any adjustments to guidance that were not as robust as anticipated by the market, even if minor, could lead to a slight stock price adjustment.

**5. Absence of Strong New Catalysts to Drive Significant Growth:** Despite positive developments such as a Moody's credit rating upgrade on September 10, 2025, and improvements in senior housing occupancy, the period lacked a significant new catalyst to strongly drive the stock higher. The dividend also remained constant. This, coupled with general market scrutiny of REIT valuations and the broader interest rate environment, may have allowed minor selling pressure or profit-taking to result in the observed small decline.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
SBRA Return-11%-16%0%26%31%16%44%
Peers Return-6%6%-9%24%31%34%99%
S&P 500 Return16%27%-19%24%23%16%112%

Monthly Win Rates [3]
SBRA Win Rate67%50%50%50%67%50% 
Peers Win Rate63%53%50%62%70%62% 
S&P 500 Win Rate58%75%42%67%75%73% 

Max Drawdowns [4]
SBRA Max Drawdown-72%-23%-12%-16%-10%-7% 
Peers Max Drawdown-63%-12%-22%-5%-9%-4% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: WELL, VTR, OHI, NHI, CTRE.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/19/2025 (YTD)

How Low Can It Go

Unique KeyEventSBRAS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-45.7%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven84.0%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven543 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-73.5%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven277.5%51.3%
2020 Covid PandemicTime to BreakevenTime to BreakevenNot Fully Recovered days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-44.7%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven80.9%24.7%
2018 CorrectionTime to BreakevenTime to BreakevenNot Fully Recovered days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-59.3%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven145.6%131.3%
2008 Global Financial CrisisTime to BreakevenTime to BreakevenNot Fully Recovered days1,480 days

Compare to VTR, OHI, HR, UHT, WELL


In The Past

Sabra Health Care REIT's stock fell -45.7% during the 2022 Inflation Shock from a high on 7/29/2021. A -45.7% loss requires a 84.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Sabra Health Care REIT (SBRA)

Better Bets than Sabra Health Care REIT (SBRA)

Trade Ideas

Select past ideas related to SBRA. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
MPW_10312025_Short_Squeeze10312025MPWMedical Properties TrustSpecialShort Squeeze PotentialShort Squeeze Potential
Has potential for a short squeeze. High short interest, rising short interest and high debt.
1.1%1.1%-5.8%
SBRA_6302020_Dip_Buyer_ValueBuy06302020SBRASabra Health Care REITDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
26.0%35.7%-7.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
MPW_10312025_Short_Squeeze10312025MPWMedical Properties TrustSpecialShort Squeeze PotentialShort Squeeze Potential
Has potential for a short squeeze. High short interest, rising short interest and high debt.
1.1%1.1%-5.8%
SBRA_6302020_Dip_Buyer_ValueBuy06302020SBRASabra Health Care REITDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
26.0%35.7%-7.0%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Sabra Health Care REIT

Peers to compare with:

Financials

SBRAWELLVTROHINHICTREMedian
NameSabra He.WelltowerVentas Omega He.National.CareTrus. 
Mkt Price18.69186.0179.1043.9777.8436.3360.91
Mkt Cap4.5125.136.113.03.77.710.4
Rev LTM7459,7525,5551,150356324948
Op Inc LTM2671,580818718184181492
FCF LTM3412,746968877226334609
FCF 3Y Avg3132,065687723200225500
CFO LTM3412,7871,549877226348613
CFO 3Y Avg3132,1131,297723202235518

Growth & Margins

SBRAWELLVTROHINHICTREMedian
NameSabra He.WelltowerVentas Omega He.National.CareTrus. 
Rev Chg LTM8.9%32.6%15.7%13.7%8.1%47.6%14.7%
Rev Chg 3Y Avg7.8%20.9%10.7%6.3%8.7%21.2%9.7%
Rev Chg Q6.8%30.7%20.4%12.9%8.3%82.4%16.7%
QoQ Delta Rev Chg LTM1.6%6.8%4.8%3.2%2.0%17.0%4.0%
Op Mgn LTM35.8%16.2%14.7%62.4%51.6%55.7%43.7%
Op Mgn 3Y Avg35.5%15.1%12.0%54.3%53.1%57.4%44.3%
QoQ Delta Op Mgn LTM-1.3%0.7%0.0%0.1%-1.7%0.9%0.1%
CFO/Rev LTM45.8%28.6%27.9%76.2%63.7%107.4%54.7%
CFO/Rev 3Y Avg45.2%26.8%26.3%71.6%60.9%93.2%53.0%
FCF/Rev LTM45.8%28.2%17.4%76.2%63.5%103.2%54.7%
FCF/Rev 3Y Avg45.2%26.1%13.8%71.6%60.1%88.9%52.6%

Valuation

SBRAWELLVTROHINHICTREMedian
NameSabra He.WelltowerVentas Omega He.National.CareTrus. 
Mkt Cap4.5125.136.113.03.77.710.4
P/S6.012.86.511.310.423.710.8
P/EBIT15.583.345.116.518.425.622.0
P/E25.6130.2151.624.125.129.427.5
P/CFO13.144.923.314.816.322.119.2
Total Yield10.3%0.8%2.9%10.0%8.5%4.9%6.7%
Dividend Yield6.4%0.0%2.3%5.9%4.5%1.5%3.4%
FCF Yield 3Y Avg7.9%2.7%2.8%7.0%6.4%5.0%5.7%
D/E0.60.10.40.40.30.10.3
Net D/E0.50.10.30.30.30.00.3

Returns

SBRAWELLVTROHINHICTREMedian
NameSabra He.WelltowerVentas Omega He.National.CareTrus. 
1M Rtn-0.2%-7.0%-0.2%-2.4%-1.3%-1.0%-1.2%
3M Rtn1.5%13.0%18.7%7.6%0.3%6.8%7.2%
6M Rtn5.8%24.0%28.5%23.0%12.7%23.4%23.2%
12M Rtn17.9%51.9%38.6%24.5%17.1%38.7%31.6%
3Y Rtn92.7%209.5%94.1%98.3%71.5%124.3%96.2%
1M Excs Rtn-2.5%-8.4%-4.0%-4.6%-2.9%-3.5%-3.7%
3M Excs Rtn0.6%9.4%16.6%6.7%-1.5%5.7%6.2%
6M Excs Rtn-9.6%8.3%12.9%8.4%-3.2%7.5%7.9%
12M Excs Rtn0.4%33.5%22.3%6.8%1.0%20.0%13.4%
3Y Excs Rtn14.7%125.4%18.0%18.2%-4.6%43.7%18.1%

Financials

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Single segment648    
Interest and other income 38171282
Rental and related revenues 401397431452
Resident fees and services 187156156128
Total648625570599662


Price Behavior

Short Interest

Short Interest: As Of Date11282025
Short Interest: Shares Quantity23,647,917
Short Interest: % Change Since 1115202521.5%
Average Daily Volume2,700,777
Days-to-Cover Short Interest8.76
Basic Shares Quantity239,896,059
Short % of Basic Shares9.9%

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/5/20253.6%5.4%7.4%
8/4/2025-1.2%1.2%4.9%
5/5/20253.5%3.6%3.8%
2/19/2025-1.0%-1.0%4.7%
10/31/2024-3.9%-0.4%-3.7%
8/7/2024-1.2%-1.4%5.5%
5/8/2024-2.6%-2.4%-3.9%
2/27/2024-0.2%-0.7%3.9%
...
SUMMARY STATS   
# Positive61015
# Negative18149
Median Positive3.4%2.6%4.7%
Median Negative-1.6%-2.1%-5.0%
Max Positive8.5%11.9%46.5%
Max Negative-13.3%-11.1%-57.4%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251105202510-Q 9/30/2025
6302025804202510-Q 6/30/2025
3312025505202510-Q 3/31/2025
12312024219202510-K 12/31/2024
93020241031202410-Q 9/30/2024
6302024807202410-Q 6/30/2024
3312024508202410-Q 3/31/2024
12312023227202410-K 12/31/2023
93020231106202310-Q 9/30/2023
6302023807202310-Q 6/30/2023
3312023503202310-Q 3/31/2023
12312022221202310-K 12/31/2022
93020221107202210-Q 9/30/2022
6302022803202210-Q 6/30/2022
3312022504202210-Q 3/31/2022
12312021222202210-K 12/31/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value
Value of
Held Shares
Form
0FOSTER MICHAEL J 5222025Sell18.2211,000200,3761,179,031Form
1Cusack Catherine 2252025Buy16.431,00016,435971,029Form